首页> 外文会议>International Conference on Bioinformatics and Biomedical Engineering >MRTF-A Decreases the Anti-tumor Effect of Tamoxifen on MCF-7 Human Breast Cancer Cells
【24h】

MRTF-A Decreases the Anti-tumor Effect of Tamoxifen on MCF-7 Human Breast Cancer Cells

机译:MRTF-A降低Tamoxifen对MCF-7人乳腺癌细胞的抗肿瘤作用

获取原文

摘要

Myocardin-related transcription factors A (MRTF-A) is a myocardin-related transcription factor that has been found strongly activated CarG box - containing genes through its direct binding to serum response factor (SRF). In the present study, the MRTF-A expression vector was constructed. The MTT assay showed that transfection of MRTF-A could significantly decrease the anti-tumor effect of tamoxifen on MCF-7 human breast cancer cells. The bioinformatics analysis found that the CarG element existed in the promoter region of COMT gene of many familiar vertebrates, including of human, rhesus macaque, chimpanzee, etc. The results of RT-PCR assay further showed that MRTF-A could enhance the transcription level of COMT. These results are the first to indicate that COMT might be a target gene which could be regulated by MRTF-A/SRF, and such transactivation event might be involved in the process of tamoxifen resistance.
机译:心肌素相关的转录因子A(MRTF-A)是一种心肌素相关的转录因子,通过其直接结合血清响应因子(SRF)发现含有强烈的克隆盒的基因。在本研究中,构建MRTF-A表达载体。 MTT测定表明,MRTF-A的转染可能会显着降低他莫昔芬对MCF-7人乳腺癌细胞的抗肿瘤作用。生物信息学分析发现,克隆元素存在于许多熟悉的脊椎动物的Comt基因的启动子区,包括人,恒星猕猴,黑猩猩等.RT-PCR测定的结果进一步表明MRTF-A可以增强转录水平comt。这些结果是第一种表示COMT可能是通过MRTF-A / SRF来调节的靶基因,并且这种转移事件可能参与他莫氧基抗性的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号